【正文】 、 Business culture Text 一、 Brief introduction （一） Our pany Hubei Longdan Biological Medicine Co,. Ltd was reestablished based upon Hubei Longdan Medicine Co,. Ltd on December 1, 2020. As a major national grade hitech enterprise which entitled to provincial and metropolitan governmentsˊ support, we research, develop and sale Chinese herbal medicine, Western medicine, biological medicine and healthprevent medicine, etc. Our pany situates in Wuhan Eastlake Hitech Development Zone. We possess strong technology power. At present, we have a total amount of staff of more than 200, among them there are 70 technicians, 7 doctors, 4 aftergraduates and more than 90% of whom are above junior college level. Our strategy of developing medicinal products is to “ produce, research and restore” a generation respectively. Up to now, we have produced many types of doses as tablet, capsule, granule, pill, moisture, oral and alcoholic doses (including more than 200 patterns) With which there are 6 national new medicines and 8 authorized national new medicines. In all, our products covers many fields such as lead poisoning, cancers, liver disease, male genitals, diabetes, coronary heart disease, antibacteria, inflammation diminishing and lack of whey after childbirth. We have four subsidiaries. They are Hubei Kangengde Medicine Co,. Ltd, Hubei Fuhua Medicine Co,. Ltd, Hubei Huirui Pharmacy Co,. Ltd and Hubei Guangren Medicine Co,.Ltd. （二） Organization and senior executives 【 Organization】 Marketing centre centre Board of directors Supervisors’ meeting CEO Assistant CEO No. 1 Business designing centre Executive office Manpower department Transportation team Manufacturing centre President Assistant CEO No. 2 Research and development centre CEO office Capital running department Assistant CEO No. 4 Assistant CEO No. 3 Experts group Auditing office Financial management dep. New drug developing centre Stockholders’ meeting 【 Senior executives】 Zhi Lingzhang 42 yearold. He has graduated from Beijing Chinese Medicine College. He was an outpatient physician of Yichang Red Cross Hospital from 1985 to 1988. He founded Wuhan Longren Medicine Institute in 1992. He was chosen as representative of people′ s conference of Hanyang district and voted as missioner of the tenth political counseling meeting of Wuhan city in 2020. He possesses powerful professional knowledge as a result of years of devoted researching and developing of Chinese herbal medicine technology. 【 Other management cadres】 Minyi Xia 38 yearold, standing vice president, professional agent. He has undertoken marketing study, saleplan designation and real operation for many years. He has been the southwest district president of Kangwei Medicine Co,. Ltd and chief designation supervisor of Xiuzheng Medicine Co,. Ltd. Qunbo Zhen 36 yearold, general manager of sale department. He has graduated from Henan Chinese Medical institute and whom is studying MBA course at Huazhong Science and Technology University. Mr. Zhang has worked at several prehensive pharmaceutical panies sequentially as sale managers and thus achieved much as for management and marketing. Qiuying Zhan 52 yearold, chief financial supervisor, graduate. He has graduated from Zhongnan Finance and Law University. He possesses strong knowledge of professional has been financial chief at Mailyard Group for many years and thus made him rich of experiences. Jie Yan 37 yearold, engineer general. She has graduated from Tianjin Medical College and been studied in Japan afterward. She is acplished in researching and developing new medicines and whom is now in charge of this task at our pany. 二、 Industry condition and our petition advantages （一） National policy and international background Medicine industry is different with any other walk as it is in close relationship with people′ s health and even lives. For this reason, Chinese government has checked and neatened medicine market with powerful measures we have never heard of. At present, following measures are taken to normalize Chinese medicine market: 1. Legislation for medicine is fastened and system of medical rules is perfected。 2. Compulsory enforcement of GMP and implementation of series standards of ISO9000。 4. Fastening price reform of medicines。 6. Materialization of exclusive sale as for medicine. Chinese entrance of WTO brings about tremendous opportunities for our pany. We are adjusting our marketing strategy and developing countermeasures and the following steps adopted: 1. To introduce advanced equipments for biological medicine manufacturing from home and abroad and thus bring remarkable progress with our productivity, quality control and craftwork so as to satisfy the requirements of global market 。 3. To integrate resources and sale channels so as to promote our marketing shares by means of union, coinvestment and cooperation with domestic pharmaceutical enterprises 。 2. Compulsory enforcement of GMP and implementation of series standards of ISO9000。 4. Fastening price reform of medicines。 6. Materialization of exclusive sale as for medicine. Chinese entrance of WTO brings about tremendous opportunities for our pany. We are adjusting our marketing strategy and developing countermeasures and the following steps adopted: 5. To introduce advanced equipments for biological medicine manufacturing from home and abroad and thus bring remarkable progress with our